Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
In laboratory studies, TB-500 has been evaluated for its interaction with actin-binding pathways, cytoskeletal organization, and cellular migration processes
Lower risk of hitting a nerve, bone, or major blood vessel
What to Expect with Treatment: Most patients using AOD-9604 under medical supervision report gradual improvements in body composition over 8-12 weeks
Thymosin Beta 4: A Potential Novel Therapy for Neurotrophic Keratopathy, Dry Eye, and Ocular Surface Diseases
US$ 27.12
US$ 22.83
US$ 25.42
US$ 23.23
US$ 20.30
US$ 20.06
